







































Emmanuel Ifeanyi Obeagu                                                                                                      Asian Journal of Dental and Health Sciences. 2025; 5(1):20-24 

[20]                                                                                                                                                                                                                                              AJDHS.COM 

 

 

Available online at ajdhs.com 

Asian Journal of Dental and Health Sciences 
Open Access to Dental and Medical Research 

Copyright  © 2025 The  Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 
which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the 

original author and source are credited  

 

 

Assessing Anemia in Pregnant Women: The Usefulness of the Mentzer Index 

Emmanuel Ifeanyi Obeagu *  

Department of Biomedical and Laboratory Science, Africa University, Zimbabwe 

Article Info: 
_____________________________________________ 
Article History: 

Received   08 Nov 2024     
Reviewed  20 Dec 2024 
Accepted   15 Jan 2025 
Published 15 March 2025 

_____________________________________________ 
Cite this article as:  

Obeagu EI, Assessing Anemia in Pregnant 
Women: The Usefulness of the Mentzer Inde, 
Asian Journal of Dental and Health Sciences. 2025; 
5(1):20-24                                                                    

DOI: http://dx.doi.org/10.22270/ajdhs.v5i1.114            

Abstract 
_________________________________________________________________________________________________________________ 

Anemia during pregnancy is a prevalent concern, with iron deficiency anemia (IDA) and thalassemia 
trait (TT) being two common causes. Differentiating between these conditions is crucial for effective 
management, as IDA requires iron supplementation, while TT does not. The Mentzer Index (MI) is a 
simple, cost-effective tool used to distinguish between IDA and TT by analyzing the mean 
corpuscular volume (MCV) and red blood cell (RBC) count. This review explores the usefulness of 
the Mentzer Index in assessing anemia in pregnant women, its clinical applications, benefits, and 
limitations in practice. The Mentzer Index provides a quick and efficient means of diagnosing anemia 
types by calculating the ratio of MCV to RBC. A value below 13 typically suggests thalassemia trait, 
while a higher value points to iron deficiency anemia. In pregnancy, where anemia is common due to 
increased iron demands, the Mentzer Index serves as an essential tool to guide treatment decisions. 
By helping clinicians avoid unnecessary iron supplementation in women with thalassemia, it reduces 
the risk of complications such as iron overload, thereby improving patient outcomes. 

Keywords: Anemia, Pregnant Women, Mentzer Index, Iron Deficiency, Thalassemia 

*Address for Correspondence:   

Emmanuel Ifeanyi Obeagu, Department of Biomedical and Laboratory Science, Africa University, Zimbabwe 

 

Introduction 

Anemia during pregnancy is a widespread condition 
that affects millions of women worldwide, with a 
significant impact on maternal and fetal health. It is 
particularly prevalent in low- and middle-income 
countries, where nutritional deficiencies, especially iron 
deficiency, are more common. Anemia in pregnancy has 
been linked to a variety of adverse outcomes, including 
preterm birth, low birth weight, maternal fatigue, and in 
severe cases, maternal mortality. The most common 
cause of anemia in pregnancy is iron deficiency anemia 
(IDA), but other conditions such as thalassemia trait 
(TT) can also lead to similar symptoms, making the 
diagnosis of anemia more complex. Accurate 
identification of the underlying cause is crucial for 
providing appropriate treatment and preventing 
complications.1-2 Iron deficiency anemia and 
thalassemia trait are both types of microcytic anemia, 
which means they are characterized by smaller-than-
normal red blood cells (RBCs). However, the causes of 
these conditions are vastly different. IDA is caused by a 
deficiency of iron, which is necessary for hemoglobin 
production, leading to reduced oxygen-carrying capacity 
in the blood. On the other hand, thalassemia is a genetic 
disorder that affects hemoglobin production, leading to 
the production of abnormal hemoglobin chains. While 
both conditions present with low hemoglobin levels and 
microcytosis, the treatment strategies are entirely 
different. Iron supplementation is effective for IDA, but 

it is contraindicated in thalassemia, as it can lead to iron 
overload and associated complications such as organ 
damage.3-4 

The challenge in differentiating between IDA and 
thalassemia is compounded during pregnancy, a time 
when physiological changes can influence laboratory 
results. For instance, pregnancy-induced changes in 
blood volume and red blood cell mass can lead to a 
dilutional effect, making it difficult to interpret routine 
blood tests. Additionally, some women may present 
with mixed anemia, such as a combination of iron 
deficiency and thalassemia trait, further complicating 
diagnosis and treatment. Therefore, accurate and 
reliable diagnostic tools are needed to distinguish 
between the different types of anemia and guide 
appropriate treatment.5 One such tool is the Mentzer 
Index (MI), which provides a quick and effective method 
for distinguishing between IDA and thalassemia trait. 
The Mentzer Index is calculated by dividing the mean 
corpuscular volume (MCV) by the red blood cell (RBC) 
count. A lower MI value (typically below 13) suggests 
thalassemia trait, while a higher value indicates iron 
deficiency anemia. This simple formula is easy to 
calculate from routine blood tests, making it an 
accessible and cost-effective tool for healthcare 
providers, especially in resource-limited settings. The 
Mentzer Index has gained recognition in clinical practice 
for its ability to quickly differentiate between these two 
common causes of anemia.6 The use of the Mentzer 

                     Open Access                                                                                                                                                                                                                Review Article                                                                           

http://jddtonline.info/
http://dx.doi.org/10.22270/ajdhs.v5i1.114
https://crossmark.crossref.org/dialog/?doi=10.22270/ajdhs.v5i1.114&amp;domain=pdf
https://orcid.org/0000-0002-4538-0161


Emmanuel Ifeanyi Obeagu                                                                                                      Asian Journal of Dental and Health Sciences. 2025; 5(1):20-24 

[21]                                                                                                                                                                                                                                              AJDHS.COM 

Index in pregnant women is particularly valuable, as 
early identification of anemia type can lead to more 
targeted treatment. In cases of iron deficiency anemia, 
iron supplementation can be prescribed to address the 
deficiency and improve maternal and fetal health 
outcomes. Conversely, in women with thalassemia trait, 
unnecessary iron supplementation can be avoided, 
preventing the risk of iron overload and its associated 
complications. Furthermore, by providing a rapid 
assessment of anemia type, the Mentzer Index can guide 
further diagnostic testing, such as hemoglobin 
electrophoresis or serum ferritin levels, which may be 
required to confirm the diagnosis.7-8 

The Mentzer Index: Calculation and 
Interpretation 

The Mentzer Index (MI) is a diagnostic tool used to 
differentiate between two common causes of microcytic 
anemia: iron deficiency anemia (IDA) and thalassemia 
trait (TT).  The MCV is a measure of the average size of 
red blood cells, and the RBC count is the total number of 
red blood cells in a given volume of blood. These values 
are typically obtained from a standard complete blood 
count (CBC), which is one of the most commonly 
ordered laboratory tests in clinical practice. The 
Mentzer Index provides an efficient and cost-effective 
method for distinguishing between IDA and TT, as these 
two conditions have different underlying causes and 
require different management strategies.9-10 

Interpretation of the Mentzer Index is based on the 
following general guidelines: 

• Mentzer Index < 13: A lower MI value suggests 
thalassemia trait. In TT, the RBC count is usually 
normal or elevated, while the MCV is low due to the 
presence of abnormal hemoglobin. As a result, the MI 
value falls below the threshold of 13, indicating the 
need for further investigation, such as hemoglobin 
electrophoresis, to confirm the presence of 
thalassemia.11 

• Mentzer Index > 13: A higher MI value suggests 
iron deficiency anemia. In IDA, the MCV is low due to 
insufficient iron, which is necessary for hemoglobin 
synthesis. However, the RBC count may be low due 
to a decrease in overall red blood cell production. 
Therefore, a higher MI value points to iron 
deficiency, prompting the initiation of iron 
supplementation and further investigation into iron 
stores (e.g., serum ferritin levels).12 

• Mentzer Index between 13 and 15: In some cases, 
the MI value falls within a gray zone between these 
two conditions, particularly in cases of mixed 
anemia, such as the presence of both iron deficiency 
and thalassemia trait. In these situations, additional 
diagnostic tests, such as serum ferritin levels or 
hemoglobin electrophoresis, are recommended to 
obtain a definitive diagnosis.13 

Application of the Mentzer Index in Pregnancy 

The application of the Mentzer Index in pregnancy plays 
a crucial role in the timely and accurate differentiation 

between iron deficiency anemia (IDA) and thalassemia 
trait (TT), two common causes of microcytic anemia 
that can occur during pregnancy. Pregnant women are 
particularly susceptible to anemia due to increased iron 
demands, blood volume expansion, and the 
physiological changes that occur throughout pregnancy. 
As anemia can negatively impact both maternal and 
fetal health, accurate diagnosis is essential for 
appropriate management. The Mentzer Index, a simple 
and cost-effective diagnostic tool, assists clinicians in 
identifying the underlying cause of anemia by analyzing 
the mean corpuscular volume (MCV) and red blood cell 
(RBC) count from routine blood tests.14-15 Pregnancy 
increases the body's iron requirements due to the 
expansion of maternal blood volume, fetal iron 
demands, and placental growth. As a result, iron 
deficiency anemia is particularly common during 
pregnancy, especially in women with poor dietary 
intake, excessive blood loss, or preexisting conditions 
that impair iron absorption. The Mentzer Index can help 
differentiate IDA from thalassemia trait, which is also 
characterized by microcytosis but has a different 
pathophysiology. Thalassemia, a genetic disorder that 
leads to abnormal hemoglobin production, often 
presents with low MCV values, similar to IDA. However, 
in contrast to IDA, women with thalassemia trait 
generally do not require iron supplementation, and 
unnecessary iron therapy can lead to complications, 
such as iron overload. The Mentzer Index provides a 
rapid and simple method to help distinguish these two 
conditions, guiding clinicians in their treatment 
decisions.16 The clinical utility of the Mentzer Index in 
pregnancy is particularly important in reducing the risk 
of misdiagnosis and unnecessary treatments. In cases 
where the Mentzer Index suggests iron deficiency 
anemia (MI > 13), iron supplementation is typically 
initiated to address the deficiency and support both 
maternal and fetal health. However, when the MI is low 
(MI < 13), indicating thalassemia trait, iron 
supplementation is avoided, preventing the risk of iron 
overload, which could lead to complications such as 
organ damage. Furthermore, the Mentzer Index serves 
as an effective screening tool in resource-limited 
settings, where more expensive diagnostic tests such as 
hemoglobin electrophoresis may not be readily 
available. It offers a quick, accessible, and reliable 
means to guide further diagnostic testing, ensuring 
accurate management of anemia in pregnant women.17 

Benefits of the Mentzer Index in Clinical 
Practice 

The Mentzer Index (MI) offers several benefits in 
clinical practice, especially in the diagnosis and 
management of anemia, particularly in differentiating 
between iron deficiency anemia (IDA) and thalassemia 
trait (TT). Its advantages lie in its simplicity, cost-
effectiveness, and ability to provide rapid insights, 
making it an invaluable tool for healthcare providers, 
especially in resource-limited settings.18 

1. Simplicity and Quick Calculation: One of the 
primary benefits of the Mentzer Index is its 
simplicity. It is calculated using two standard 



Emmanuel Ifeanyi Obeagu                                                                                                      Asian Journal of Dental and Health Sciences. 2025; 5(1):20-24 

[22]                                                                                                                                                                                                                                              AJDHS.COM 

laboratory values: the mean corpuscular volume 
(MCV) and red blood cell (RBC) count, both of which 
are routinely measured in a complete blood count 
(CBC).19 

2. Cost-Effective: The Mentzer Index is a low-cost 
diagnostic tool, particularly beneficial in low-
resource or underserved settings where more 
expensive tests, such as hemoglobin electrophoresis, 
may not be available. By relying on routine CBC 
results, the MI allows for the initial screening of 
anemia types without the need for specialized 
equipment or procedures, making it an affordable 
and accessible option for healthcare facilities in both 
developed and developing regions.20 

3. Differentiation Between Iron Deficiency and 
Thalassemia: The Mentzer Index excels at 
distinguishing between two common causes of 
microcytic anemia—iron deficiency anemia (IDA) 
and thalassemia trait (TT). This differentiation is 
crucial because the management of these two 
conditions is markedly different. Iron deficiency 
anemia requires iron supplementation, while 
thalassemia trait does not. By providing a simple and 
rapid means of distinguishing between these two 
conditions, the Mentzer Index helps clinicians avoid 
the risk of misdiagnosis and unnecessary treatments, 
such as iron supplementation in patients with 
thalassemia trait.21 

4. Guiding Further Diagnostic Testing: While the 
Mentzer Index is useful for initial screening, it also 
serves as a guide for more comprehensive diagnostic 
investigations. If the MI suggests thalassemia trait 
(MI < 13), further testing, such as hemoglobin 
electrophoresis, can confirm the diagnosis. Similarly, 
if the MI is high (MI > 13), indicating iron deficiency 
anemia, the next step would typically involve 
measuring serum ferritin levels to assess iron stores 
and confirm the diagnosis. This stepwise approach 
reduces the likelihood of misdiagnosis and ensures 
that patients receive the appropriate interventions.22 

5. Improved Patient Management: The rapid results 
from the Mentzer Index enable timely and 
appropriate treatment, enhancing patient outcomes. 
For example, if iron deficiency anemia is suspected, 
prompt iron supplementation can be initiated to 
prevent complications such as maternal fatigue, low 
birth weight, and preterm birth. On the other hand, 
in cases of thalassemia trait, unnecessary iron 
supplementation is avoided, which helps prevent 
iron overload and its associated risks, such as organ 
damage. The ability to make informed clinical 
decisions based on the Mentzer Index helps ensure 
that patients receive the correct treatment for their 
specific condition.23 

6. Universal Applicability in Various Settings: The 
Mentzer Index is versatile and can be applied across 
diverse patient populations, including pregnant 
women, children, and adults. It is particularly 
valuable in high-risk groups, such as pregnant 
women, where anemia is common and distinguishing 

between iron deficiency and thalassemia is critical 
for ensuring proper management. Additionally, its 
utility in low-resource settings where access to 
advanced diagnostic tools is limited further amplifies 
its significance in improving anemia diagnosis and 
management worldwide.24 

Limitations and Challenges of the Mentzer 
Index 

While the Mentzer Index (MI) is a valuable and widely 
used diagnostic tool for differentiating between iron 
deficiency anemia (IDA) and thalassemia trait (TT), it is 
not without limitations and challenges that clinicians 
must consider when using it in practice. These 
limitations can affect its reliability and accuracy in 
certain patient populations or clinical situations, which 
can lead to misdiagnosis or inappropriate management 
if not carefully interpreted. 

1. Reliability in Mixed Anemia: One of the primary 
limitations of the Mentzer Index is its reduced 
reliability in cases of mixed anemia, where both iron 
deficiency and thalassemia trait coexist. In such 
cases, the MCV and RBC count values may not 
consistently fit the typical patterns seen in pure IDA 
or TT, leading to ambiguous or borderline MI values. 
This could make it difficult to accurately differentiate 
between the two conditions. For example, in some 
patients with coexisting iron deficiency and 
thalassemia trait, the MI may fall within the "gray 
zone" (between 13 and 15), requiring further 
diagnostic tests such as hemoglobin electrophoresis 
or serum ferritin measurements for clarification.25 

2. Influence of Other Causes of Microcytosis: The 
Mentzer Index is most useful in distinguishing 
between IDA and thalassemia trait in cases of 
microcytic anemia, but it may not be reliable when 
anemia is caused by other factors, such as anemia of 
chronic disease, lead poisoning, or vitamin 
B12/folate deficiencies. These conditions can also 
present with low MCV values but have entirely 
different pathophysiological mechanisms and 
management strategies. The MI does not account for 
these other causes of anemia, which can lead to 
misdiagnosis and inappropriate treatment if 
clinicians rely solely on the MI for diagnosis.25 

3. Variation in Laboratory Measurements: The 
accuracy of the Mentzer Index depends on the 
precision of the laboratory measurements used to 
calculate the MCV and RBC count. Inaccuracies in 
these values, due to technical factors or differences 
in laboratory equipment and methods, can affect the 
validity of the MI calculation. Additionally, variations 
in patient demographics (such as age, sex, or 
ethnicity) may influence the interpretation of MCV 
and RBC values, further complicating the MI's 
diagnostic utility. In clinical settings, especially in 
resource-limited areas, inconsistencies in laboratory 
techniques may reduce the reliability of the MI as a 
diagnostic tool.26 

4. Limited to Microcytic Anemia: The Mentzer Index 
is specifically designed to evaluate microcytic 



Emmanuel Ifeanyi Obeagu                                                                                                      Asian Journal of Dental and Health Sciences. 2025; 5(1):20-24 

[23]                                                                                                                                                                                                                                              AJDHS.COM 

anemia, where the red blood cells are smaller than 
normal. It is not applicable for diagnosing macrocytic 
or normocytic anemias, which can be caused by a 
variety of other factors, such as vitamin deficiencies, 
chronic disease, or bone marrow disorders. This 
limitation means that while the MI is valuable for 
differentiating between IDA and TT, it does not 
address other causes of anemia and should not be 
used as a sole diagnostic tool in broader anemia 
evaluations.27 

5. Inadequate for Severe Thalassemia or Anemia of 
Chronic Disease: In patients with severe 
thalassemia or anemia of chronic disease, the MI may 
not provide a clear distinction between these 
conditions and IDA. Severe thalassemia can present 
with low MCV values but may not follow the typical 
pattern that the Mentzer Index is designed to 
identify. Similarly, anemia of chronic disease often 
presents with normocytic or microcytic anemia, but 
the MI may not be sensitive enough to differentiate 
this from iron deficiency anemia or thalassemia trait. 
In such cases, more specific tests, such as serum iron 
studies, ferritin levels, or hemoglobin 
electrophoresis, are necessary for an accurate 
diagnosis.27 

6. Lack of Standardization and Consensus: While the 
Mentzer Index is widely used, there is no universal 
agreement on the exact cut-off values for 
interpretation. Some sources suggest that a MI below 
13 indicates thalassemia trait, while others may 
propose different thresholds. This lack of 
standardization can lead to variations in clinical 
practice and potential inconsistencies in diagnosis. 
As a result, healthcare providers should exercise 
caution when interpreting the MI and consider it as 
part of a broader diagnostic workup, incorporating 
clinical findings and additional tests to confirm the 
diagnosis. 

Conclusion 

In conclusion, the Mentzer Index (MI) remains a 
valuable and cost-effective tool in the diagnosis of 
microcytic anemia, particularly in differentiating 
between iron deficiency anemia (IDA) and thalassemia 
trait (TT). Its simplicity, ease of calculation, and ability 
to provide rapid insights make it an attractive option, 
especially in resource-limited settings where advanced 
diagnostic tools may not be readily available. The MI 
offers a quick and accessible means to guide clinical 
decision-making, potentially reducing unnecessary 
treatments, such as iron supplementation, and 
improving patient outcomes. 

However, despite its advantages, the Mentzer Index has 
limitations that must be recognized and addressed. It is 
less reliable in cases of mixed anemia, where both IDA 
and TT coexist, and it may not be effective in diagnosing 
other causes of microcytic anemia, such as anemia of 
chronic disease or lead poisoning. Additionally, 
variations in laboratory techniques and patient 
demographics can affect the accuracy of MI calculations, 
leading to potential misdiagnosis. Thus, while the MI 

serves as a helpful screening tool, it should not be used 
in isolation but rather as part of a comprehensive 
diagnostic approach that includes further confirmatory 
tests such as hemoglobin electrophoresis or serum 
ferritin measurements. 

Conflict of Interest: Author declares no potential 

conflict of interest with respect to the contents, 

authorship, and/or publication of this article. 

Source of Support: Nil 

Funding: The authors declared that this study has 

received no financial support. 

Informed Consent Statement: Not applicable.  

Data Availability Statement: The data supporting in 

this paper are available in the cited references.  

Ethics approval: Not applicable. 

References 

1. Rahman MM, Abe SK, Rahman MS, Kanda M, Narita S, Bilano V, Ota 
E, Gilmour S, Shibuya K. Maternal anemia and risk of adverse birth 
and health outcomes in low-and middle-income countries: 
systematic review and meta-analysis. The American journal of 
clinical nutrition. 2016; 103(2):495-504. 
https://doi.org/10.3945/ajcn.115.107896 PMid:26739036 

2. Obeagu EI, Ezimah AC, Obeagu GU. Erythropoietin in the anaemias 
of pregnancy: a review. Int J Curr Res Chem Pharm Sci. 
2016;3(3):10-18. https://doi.org/10.22270/ijmspr.v10i2.95 

3. Okamgba OC, Nwosu DC, Nwobodo EI, Agu GC, Ozims SJ, Obeagu EI, 
Ibanga IE, Obioma-Elemba IE, Ihekaire DE, Obasi CC, Amah HC. 
Iron Status of Pregnant and Post-Partum Women with Malaria 
Parasitaemia in Aba Abia State, Nigeria. Annals of Clinical and 
Laboratory Research. 2017;5(4):206. 

4. Petrakos G, Andriopoulos P, Tsironi M. Pregnancy in women with 
thalassemia: challenges and solutions. International journal of 
women's health. 2016:441-451. 
https://doi.org/10.2147/IJWH.S89308 PMid:27660493 
PMCid:PMC5019437 

5. Obeagu EI, Adepoju OJ, Okafor CJ, Obeagu GU, Ibekwe AM, Okpala 
PU, Agu CC. Assessment of Haematological Changes in Pregnant 
Women of Ido, Ondo State, Nigeria. J Res Med Dent Sci. 2021 
Apr;9(4):145-148. 

6. Agreen FC, Obeagu EI. Anaemia among pregnant women: A review 
of African pregnant teenagers. Journal of Public Health and 
Nutrition. 2023;6(1):138. 

7. Arora S, Rana D, Kolte S, Dawson L, Dhawan I. Validation of new 
indices for differentiation between iron deficiency anemia and 
beta thalessemia trait, a study in pregnant females. International 
Journal of Scientific Reports. 2018; 4(2):26. 
https://doi.org/10.18203/issn.2454-2156.IntJSciRep20180394 

8. Obeagu EI, Obeagu GU, Insights into Maternal Health: Mentzer Index 
for Early Anemia Detection, International Journal of Medical 
Sciences and Pharma Research,2024;10(4):44-49 
https://doi.org/10.22270/ijmspr.v10i4.122 

9. Obeagu EI, Influence of Hemoglobin Variants on Vaso-Occlusive 
Phenomena in Sickle Cell Anemia: A Review, International Journal 
of Medical Sciences and Pharma Research, 2024;10(2):54-59 
https://doi.org/10.22270/ijmspr.v10i2.104 

10. Iolascon A, Andolfo I, Russo R, Sanchez M, Busti F, Swinkels D, 
Aguilar Martinez P, Bou‐Fakhredin R, Muckenthaler MU, Unal S, 
Porto G. Recommendations for diagnosis, treatment, and 
prevention of iron deficiency and iron deficiency anemia. 
Hemasphere. 2024; 8(7):e108. 
https://doi.org/10.1002/hem3.108 PMid:39011129 
PMCid:PMC11247274 

https://doi.org/10.3945/ajcn.115.107896
https://doi.org/10.22270/ijmspr.v10i2.95
https://doi.org/10.2147/IJWH.S89308
https://doi.org/10.18203/issn.2454-2156.IntJSciRep20180394
https://doi.org/10.22270/ijmspr.v10i4.122
https://doi.org/10.22270/ijmspr.v10i2.104
https://doi.org/10.1002/hem3.108


Emmanuel Ifeanyi Obeagu                                                                                                      Asian Journal of Dental and Health Sciences. 2025; 5(1):20-24 

[24]                                                                                                                                                                                                                                              AJDHS.COM 

11. Obeagu EI, Obeagu GU, Chukwueze CM, Ikpenwa JN, Ramos GF. 
Evaluation of protein C, protein S and fibrinogen of pregnant 
women with malaria in Owerri metropolis. Madonna University 
journal of Medicine and Health Sciences ISSN: 2814-3035. 2022 
Apr 19;2(2):1-9. 

12. Obeagu EI, Obeagu GU. Neonatal Outcomes in Children Born to 
Mothers with Severe Malaria, HIV, and Transfusion History: A 
Review. Elite Journal of Nursing and Health Science, 2024; 2(3): 
38-58 

13. Sahli CA, Bibi A, Ouali F, Fredj SH, Dakhlaoui B, Othmani R, Laouini 
N, Jouini L, Ouenniche F, Siala H, Touhami I. Red cell indices: 
differentiation between β-thalassemia trait and iron deficiency 
anemia and application to sickle-cell disease and sickle-cell 
thalassemia. Clinical Chemistry and Laboratory Medicine (CCLM). 
2013; 51(11):2115-24. https://doi.org/10.1515/cclm-2013-0354 
PMid:23800659 

14. Hoffmann JJ, Nabbe KC, van den Broek NM. Effect of age and 
gender on reference intervals of red blood cell distribution width 
(RDW) and mean red cell volume (MCV). Clinical Chemistry and 
Laboratory Medicine (CCLM). 2015; 53(12):2015-9. 
https://doi.org/10.1515/cclm-2015-0155 PMid:26536583 

15. Miftahussurur M, Husada D, Ningtyas WS. Association Association 
Of Shine and Lal Index Β-Thalassemia Trait Screening Results with 
Anaemia and Low Birth Weigh. International Journal of Nursing 
And Midwifery Science (IJNMS). 2023; 7(3):290-296. 
https://doi.org/10.29082/IJNMS/2023/Vol7/Iss3/543 

16. Shahid H, Saleem M, Naseer N, Tabussam S, Aziz A, Ullah S. 
Evaluation of Srivastava index to distinguishing Beta-Thalassemia 
Trait from Iron Deficiency. Pakistan Journal of Medical & Health 
Sciences. 2022;16(05):1225. 
https://doi.org/10.53350/pjmhs221651225 

17. Vehapoglu A, Ozgurhan G, Demir AD, Uzuner S, Nursoy MA, 
Turkmen S, Kacan A. Hematological indices for differential 
diagnosis of Beta thalassemia trait and iron deficiency anemia. 
Anemia. 2014; 2014(1):576738. 
https://doi.org/10.1155/2014/576738 PMid:24818016 
PMCid:PMC4003757 

18. Urrechaga E. Discriminant value of% microcytic/% hypochromic 
ratio in the differential diagnosis of microcytic anemia. Clinical 
chemistry and laboratory medicine. 2008;46(12):1752-1758. 
https://doi.org/10.1515/CCLM.2008.355 PMid:19055451 

19. Obeagu EI, Obeagu GU, Anemia in Pregnancy: Mentzer Index as a 
Predictor for Iron Supplementation Needs, International Journal 
of Medical Sciences and Pharma Research, 2024;10(4):39-43 
https://doi.org/10.22270/ijmspr.v10i4.121 

20. Obeagu EI, Obeagu GU. Sickle cell anaemia in pregnancy: a review. 
International Research in Medical and Health Sciences. 2023 Jun 
10;6(2):10-13. https://doi.org/10.22270/ijmspr.v10i2.103 

21. Obeagu EI, Ubosi NI, Uzoma G. Antioxidant Supplementation in 
Pregnancy: Effects on Maternal and Infant Health. Int. J. Adv. 
Multidiscip. Res. 2023;10(11):60-70. 

22. Obeagu EI, Obeagu GU. Mitigating Oxidative Stress in Pregnancy 
through Antioxidant Supplementation: A Narrative Review. Int. J. 
Curr. Res. Chem. Pharm. Sci. 2024;11(9):7-17. 

23. Obeagu EI, Obeagu GU. Enhancing Maternal and Fetal Well-being: 
The Role of Antioxidants in Pregnancy. Elite Journal of Medical 
Sciences. 2024;2(4):76-87. 

24. Obeagu EI, Obeagu GU. Antioxidant Supplementation and 
Prevention of Early Pregnancy Loss: A Narrative Review. Int. J. 
Curr. Res. Chem. Pharm. Sci. 2024;11(9):28-37. 
https://doi.org/10.22270/ijmspr.v10i4.120 

25. Obeagu EI, Obeagu GU. Molar Pregnancy: Update of prevalence and 
risk factors. Int. J. Curr. Res. Med. Sci. 2023;9(7):25-28. 
https://doi.org/10.19080/JGWH.2023.25.556169 

26. Obeagu EI, Obeagu GU. Hypoxia-induced Metabolic Changes in 
Pregnancy: Clinical Perspectives. Elite Journal of Medicine. 
2024;2(8):50-59. 

27. Obeagu EI, Obeagu GU. Hemolysis Challenges for Pregnant Women 
with Sickle Cell Anemia: A Review. Elite Journal of Haematology. 
2024;2(3):67-80.

 

 

https://doi.org/10.1515/cclm-2013-0354
https://doi.org/10.1515/cclm-2015-0155
https://doi.org/10.29082/IJNMS/2023/Vol7/Iss3/543
https://doi.org/10.53350/pjmhs221651225
https://doi.org/10.1155/2014/576738
https://doi.org/10.1515/CCLM.2008.355
https://doi.org/10.22270/ijmspr.v10i4.121
https://doi.org/10.22270/ijmspr.v10i2.103
https://doi.org/10.22270/ijmspr.v10i4.120
https://doi.org/10.19080/JGWH.2023.25.556169

